Home   >  

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Cell Cycle/DNA Damage

Chemical Structure Cat. No. Product Name CAS No.
Leucomethylene blue Chemical Structure
BCP42937 Leucomethylene blue 613-11-6
Leucomethylene blue is a second-generation tau protein aggregation inhibitor currently in development for the treatment of Alzheimer's disease (AD) and frontotemporal dementia.
Aurora B inhibitor 1 Chemical Structure
BCP42843 Aurora B inhibitor 1 937276-52-3
Aurora B inhibitor 1 is an Aurora B (Aurora-1) inhibitor extracted from patent WO2007059299A1, compound 1-3, has a Ki value of <0.010 uM.
PF07104091 Chemical Structure
BCP42948 PF07104091 2460249-19-6
PF-07104091 is an orally bioavailable inhibitor of cyclin-dependent kinase 2 (CDK2), with potential antineoplastic activity.
Venadaparib Chemical Structure
BCP42946 Venadaparib 1681017-83-3
Venadaparib is an antineoplastic.Venadaparib is a potent, selective and orally active PARP inhibitor with IC50s of 1.4 nM and 1.0 nM for PARP1 and PARP2, respectively.
RGFP966 Chemical Structure
BCP42941 RGFP966 1396841-57-8
RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.
RBN012759 Chemical Structure
BCP42877 RBN012759 2360851-29-0
RBN012759 is a potent and selective inhibitor of PARP14 with IC50 of <3 nM and 5 nM for human catalytic domain and mouse catalytic domain, respectively. RBN012759 contributes to anti-tumor immune response.
OUN10989 HCl Chemical Structure
BCP42739 OUN10989 HCl 915413-40-0
OUN10989, an analogue compound of LP-261, is a Potent Antimitotic Agent.
OUN10989 Chemical Structure
BCP42738 OUN10989 915410-98-9
OUN10989, an analogue compound of LP-261, is a Potent Antimitotic Agent.
SCR130 Chemical Structure
BCP42678 SCR130 2377858-38-1
SCR130 is a SCR7-based DNA nonhomologous end-joining (NHEJ) inhibitor.
LY3405105 Chemical Structure
BCP42676 LY3405105 2326428-25-3
LY3405105 is an orally active CDK7 inhibitor with an IC50 of 92.8 nM. LY3405105 shows potential antineoplastic activity.
123下一页末页共 1068 条记录 1 / 107 页 
0086-15971444841